Tenable Holdings 株価情報 (NASDAQ: TENB)

最新ニュース Tenable Holdings (NASDAQ:TENB) 株価情報

Tenable Holdings

Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.

Tenable Holdings Inc

<ul>
<li>Expands Lantronix's IoT Wireless Connect Portfolio With Cutting-Edge 5G Technology</li>
<li>Strengthens Competitive Offering, Adds New Blue-Chip Customers</li>
</ul>
IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=hB3l4_jGgHsp-mU6f7YA39RB4tNFMkAA8OovErBPAK-V5ySYJi0YOjUuTG9Znzyv8NTl9eDh7MpcoWwIPs76bHVRycPMRk5eNIZ8Rnh3hyfE9uaOgBHaqhLzAkbq4hQo0VCiKCDozG3FJNNIHakKmUGncG6nXL9x4bRp7O1SQQm0gpDf9bQe79ZAY9SDAgzQ">Lantronix Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LTRX#NASDAQ">LTRX</a>), a global leader in IoT compute and connectivity IoT solutions, today announced that it has signed a definitive agreement to acquire from NetComm Wireless Pty Ltd ("NetComm"), a subsidiary of DZS, Inc., all of the assets of its enterprise Internet of Things (IoT) business for $6.5 million in cash together with assumptions of certain liabilities. The acquisition complements Lantronix's focus on the Enterprise and Smart City vertical markets and expands its next-generation 5G capabilities.

News

Asset Sales

LTRX

Lantronix Accelerates IoT Leadership With Strategic Acquisition Of DZS's NetComm Enterprise IoT Portfolio For $6.5M In Cash Together With Assumptions Of Certain Liabilities

Amplitude (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPL#NASDAQ">AMPL</a>) lowers FY2024 Adj EPS guidance from $0.05-0.08 to $0.04-0.06 vs $0.06 analyst estimate. Raises FY2024 sales outlook from $294.50 million-296.50 million to $297.10 million-298.10 million vs $295.75 million estimate.

Guidance

AMPL

Amplitude Lowers FY2024 Adj EPS Guidance from $0.05-0.08 to $0.04-0.06 vs $0.06 Est; Raises FY2024 Sales Guidance from $294.50M-296.50M to $297.10M-298.10M vs $295.75M Est

A10 Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATEN#NYSE">ATEN</a>) reported quarterly earnings of $0.21 per share which beat the analyst consensus estimate of $0.19 by 10.53 percent. This is a 31.25 percent increase over earnings of $0.16 per share from the same period last year. The company reported quarterly sales of $66.72 million which beat the analyst consensus estimate of $63.76 million by 4.64 percent. This is a 15.48 percent increase over sales of $57.77 million the same period last year.

Earnings

Earnings Beats

ATEN

A10 Networks Q3 Adj $0.21 Beats $0.19 Estimate, Sales $66.72M Beat $63.76M Estimate

Amplitude (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMPL#NASDAQ">AMPL</a>) sees Q4 sales of $76.000 million-77.000 million vs $75.73 million estimate.

Amplitude Sees Q4 Sales $76.000M-77.000M vs $75.73M Est

TBRG

TruBridge Sees Q4 Total Revenue $83.5M-$85.5M vs $84.54M Est., Sees FY24 Total Revenue $335M-$337M vs $335.92M Est.

Wheaton Precious Metals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WPM#NYSE">WPM</a>) reported quarterly earnings of $0.34 per share which missed the analyst consensus estimate of $0.35 by 2.57 percent. The company reported quarterly sales of $308.253 million which missed the analyst consensus estimate of $314.127 million by 1.87 percent. This is a 38.15 percent increase over sales of $223.137 million the same period last year.

Earnings Misses

Wheaton Precious Metals Q3 2024 GAAP EPS $0.34 Misses $0.35 Estimate, Sales $308.253M Miss $314.127M Estimate

Olo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLO#NYSE">OLO</a>) raises FY2024 sales outlook from $279.50 million-280.50 million to $281.40 million-281.90 million.

Olo Raises FY2024 Sales Guidance from $279.50M-280.50M to $281.40M-281.90M

Olo (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OLO#NYSE">OLO</a>) sees Q4 sales of $72.500 million-73.000 million vs $72.13 million estimate.

Olo Sees Q4 Sales $72.500M-73.000M vs $72.13M Est

Management

Unity Names Jarrod Yahes As CFO

Nerdy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRDY#NYSE">NRDY</a>) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.23) by 39.13 percent. This is a 55.56 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $37.530 million which beat the analyst consensus estimate of $36.670 million by 2.34 percent. This is a 6.86 percent decrease over sales of $40.296 million the same period last year.

NRDY

Nerdy Q3 2024 GAAP EPS $(0.14) Beats $(0.23) Estimate, Sales $37.530M Beat $36.670M Estimate

FormFactor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) and Advantest Corporation (TSE: 6857) announced today a strategic partnership to develop a novel test cell and measurement system designed for high-volume production of silicon photonics (SiPh) and co-packaged optics (CPO) devices. This collaboration is driven by the revolution in AI data center architectures, which require ever-increasing bandwidth while reducing power consumption. Silicon photonics is rapidly gaining traction in data centers for its ability to enable fast data transmission through optical signals, surpassing traditional electrical methods. This new test cell integrates the latest innovations from both companies, equipping photonics device developers with the tools they need to scale up volume production.

FORM

FormFactor And Advantest Partner On Silicon Photonics Wafer-Level Test Cell To Enable High-Volume Manufacturing

ARKO (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARKO#NASDAQ">ARKO</a>) reported quarterly earnings of $0.07 per share which missed the analyst consensus estimate of $0.12 by 41.67 percent. This is a 58.82 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $2.28 billion which missed the analyst consensus estimate of $2.41 billion by 5.44 percent. This is a 13.08 percent decrease over sales of $2.62 billion the same period last year.

ARKO

ARKO Q3 EPS $0.07 Misses $0.12 Estimate, Sales $2.28B Miss $2.41B Estimate

Offerings

PRPH

ProPhase Labs Announced That Intends To Sell Shares Of Its Common Stock In An Underwritten Public Offering; Terms Not Disclosed

Definitive Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) is looking for Q4 Adj EPS of $0.07 vs $0.07 analyst estimate. seessales of $60.000 million-61.000 million vs $60.28 million estimate.

Definitive Healthcare Sees Q4 Adj EPS $0.07 vs $0.07 Est; Sees Sales $60.000M-61.000M vs $60.28M Est

NWSA

News Corp Appoints Lavanya Chandrashekar As CFO; Succeeds Susan Panuccio

Definitive Healthcare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DH#NASDAQ">DH</a>) raises FY2024 Adj EPS guidance from $0.32-0.34 to $0.34-0.35 vs $0.33 analyst estimate. Raises FY2024 sales outlook from $247.00 million-251.00 million to $250.00 million-251.00 million vs $249.23 million estimate.

Definitive Healthcare Raises FY2024 Adj EPS Guidance from $0.32-0.34 to $0.34-0.35 vs $0.33 Est; Raises FY2024 Sales Guidance from $247.00M-251.00M to $250.00M-251.00M vs $249.23M Est

TruBridge (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBRG#NASDAQ">TBRG</a>) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $0.27 by 177.78 percent. The company reported quarterly sales of $83.800 million which beat the analyst consensus estimate of $82.870 million by 1.12 percent. This is a 1.32 percent increase over sales of $82.712 million the same period last year.

TruBridge Q3 2024 Adj. EPS $(0.21) Misses $0.27 Estimate, Sales $83.800M Beat $82.870M Estimate

ClearPoint Neuro (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLPT#NASDAQ">CLPT</a>) affirms FY2024 sales outlook from $30.00 million-33.00 million to $30.00 million-33.00 million.

CLPT

ClearPoint Neuro Affirms FY2024 Sales Guidance from $30.00M-33.00M to $30.00M-33.00M

Nephros (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NEPH#NASDAQ">NEPH</a>) reported quarterly sales of $3.50 million which met the analyst consensus estimate. This is a 6.47 percent decrease over sales of $3.74 million the same period last year.

NEPH

Nephros Q3 Sales $3.50M Inline

SYNA

Synaptics Sees Q2 2025 Revenue $265M +/- $15M

Sees Q4 revenue $229M-$233M, consensus $232.03M. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial ne...

Tenable sees Q4 EPS 33c-35c, consensus 32c

Tenable Holdings, Inc. (TENB) Q3 2024 Earnings Call Transcript

Analyst Hamza Fodderwala from Morgan Stanley maintained a Buy rating on Tenable Holdings (TENB – Research Report) and keeping the price target at $...

Tenable Holdings: Strong Performance and Growth Potential Justify Buy Rating

TD Cowen analyst Shaul Eyal reiterated a Buy rating on Tenable Holdings (TENB – Research Report) today and set a price target of $55.00. Shaul Eyal...

Tenable Holdings: Strong Growth Potential and Strategic Expansion Drive Buy Rating

Barclays lowered the firm's price target on Tenable (TENB) to $45 from $49 and keeps an Equal Weight rating on the shares post the Q3 report. Publi...

Tenable price target lowered to $45 from $49 at Barclays

Canaccord Genuity analyst Kingsley Crane has maintained their bullish stance on TENB stock, giving a Buy rating today. Kingsley Crane has given his...

Tenable Holdings: Strong Financial Performance and Strategic Initiatives Drive Buy Rating

Stifel Nicolaus analyst Brad Reback maintained a Buy rating on Tenable Holdings (TENB – Research Report) yesterday and set a price target of $46.00...

Stifel Nicolaus Remains a Buy on Tenable Holdings (TENB)

Truist Financial analyst Joel Fishbein maintained a Buy rating on Tenable Holdings (TENB – Research Report) yesterday and set a price target of $48...

Truist Financial Remains a Buy on Tenable Holdings (TENB)

Robert W. Baird analyst Shrenik Kothari has maintained their bullish stance on TENB stock, giving a Buy rating yesterday. Shrenik Kothari has given...

Tenable Holdings: Strong Revenue Growth and Strategic Partnerships Fuel 'Buy' Rating

Tenable Holdings (TENB) has disclosed a new risk, in the Technology category. Tenable Holdings faces significant risks by incorporating generative ...

Comments

Tenable Holdings

ニュース

最新ニュース Tenable Holdings (NASDAQ:TENB) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル